Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Viatrexx Bio Incorporated is recalling 13 vials of Viatrexx-Facial because the manufacturing process cannot guarantee sterility.
Apotex Inc. is recalling Rite Aid Pharmacy Maximum Strength Ranitidine Tablets due to possible contamination with the impurity N-nitrosodimethylamine (NDMA).
Viatrexx Bio Incorporated is recalling Viatrexx-GI sterile multi-dose vials because the manufacturing process cannot guarantee sterility. The product was distributed to physicians nationwide and in Puerto Rico.
Viatrexx Bio Incorporated is recalling Viatrexx-Infla vials because the manufacturing process cannot guarantee sterility. The product was distributed to physicians nationwide and in Puerto Rico.
Apotex Inc. is recalling Walgreens Maximum Strength Wal-Zan 150 tablets due to possible contamination with the impurity N-nitrosodimethylamine (NDMA).
Novitium Pharma LLC is recalling 2,718 bottles of Ranitidine Capsules 150 mg because the product contains the NDMA impurity.
Viatrexx Bio Incorporated is recalling Viatrexx-Intra-Cell vials because they were manufactured in a manner that cannot guarantee sterility.
Viatrexx Bio Incorporated is recalling Viatrexx-Mesenchyme vials because the manufacturing process cannot guarantee sterility. The product was distributed to physicians nationwide.
Viatrexx Bio Incorporated is recalling Viatrexx-Neuro 3 vials because the manufacturing process cannot guarantee sterility.
Novitium Pharma LLC is recalling Ranitidine Capsules 300 mg because of the presence of the NDMA impurity. The recall covers 6,660 bottles distributed nationwide.
Viatrexx Bio Incorporated is recalling 42 vials of Viatrexx-Prolo because the manufacturing process cannot guarantee sterility.
Viatrexx-Arthros is being recalled because it was manufactured in a manner that cannot guarantee sterility. The product is distributed to physicians nationwide.
Viatrexx Bio Incorporated is recalling Viatrexx-Lymph 1 vials because the manufacturing process cannot guarantee sterility.
Viatrexx Bio Incorporated is recalling Viatrexx-Connectissue vials because they were manufactured in a manner that cannot guarantee sterility.
Viatrexx Bio Incorporated is recalling Viatrexx-Adipose vials because the manufacturing process cannot guarantee sterility. The product was distributed to physicians nationwide.
Viatrexx Bio Incorporated is recalling 18 vials of Viatrexx-Immunexx because the manufacturing process cannot guarantee sterility.
Viatrexx Bio Incorporated is recalling 19 vials of Viatrexx-Ouch because the manufacturing process cannot guarantee sterility.
Viatrexx Bio Incorporated is recalling Viatrexx-ANS/CNS vials because they were manufactured in a manner that cannot guarantee sterility.
Viatrexx Bio Incorporated is recalling Viatrexx-Ithurts sterile multi-dose vials because the manufacturing process cannot guarantee sterility.
Lannett Company, Inc. is recalling 683,149 bottles of Ranitidine Syrup nationwide because NDMA impurity was detected.
Novitium Pharma LLC is recalling 19,560 bottles of Ranitidine Capsules 150 mg nationwide because the product contains the NDMA impurity.
Viatrexx Bio Incorporated is recalling Viatrexx-Relief + sterile vials because the manufacturing process cannot guarantee sterility.
Apotex Inc. is recalling Equate Maximum Strength Ranitidine Tablets due to possible contamination with the impurity N-nitrosodimethylamine (NDMA). The recall covers 1,132,453 bottles distributed nationwide.
Apotex Inc. is recalling Walgreens Regular Strength Wal-Zan 75 tablets due to possible contamination with the impurity N-nitrosodimethylamine (NDMA).
Novitium Pharma LLC is recalling Ranitidine Capsules 300 mg because the product was found to contain the NDMA impurity.